These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22494024)

  • 1. Locally resolved membrane binding affinity of the N-terminus of α-synuclein.
    Robotta M; Hintze C; Schildknecht S; Zijlstra N; Jüngst C; Karreman C; Huber M; Leist M; Subramaniam V; Drescher M
    Biochemistry; 2012 May; 51(19):3960-2. PubMed ID: 22494024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
    Stöckl M; Fischer P; Wanker E; Herrmann A
    J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein association with phosphatidylglycerol probed by lipid spin labels.
    Ramakrishnan M; Jensen PH; Marsh D
    Biochemistry; 2003 Nov; 42(44):12919-26. PubMed ID: 14596606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of a high affinity mononuclear site in the copper(II)-α-synuclein complex.
    Bortolus M; Bisaglia M; Zoleo A; Fittipaldi M; Benfatto M; Bubacco L; Maniero AL
    J Am Chem Soc; 2010 Dec; 132(51):18057-66. PubMed ID: 21141829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR.
    Ramakrishnan M; Jensen PH; Marsh D
    Biochemistry; 2006 Mar; 45(10):3386-95. PubMed ID: 16519533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spin-label EPR on alpha-synuclein reveals differences in the membrane binding affinity of the two antiparallel helices.
    Drescher M; Godschalk F; Veldhuis G; van Rooijen BD; Subramaniam V; Huber M
    Chembiochem; 2008 Oct; 9(15):2411-6. PubMed ID: 18821550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
    Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
    Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
    Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
    Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism of interaction between alpha-synuclein and biological membranes.
    Kim YS; Laurine E; Woods W; Lee SJ
    J Mol Biol; 2006 Jul; 360(2):386-97. PubMed ID: 16762368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
    Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
    Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein binds to the inner membrane of mitochondria in an α-helical conformation.
    Robotta M; Gerding HR; Vogel A; Hauser K; Schildknecht S; Karreman C; Leist M; Subramaniam V; Drescher M
    Chembiochem; 2014 Nov; 15(17):2499-502. PubMed ID: 25209675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelsolin co-occurs with Lewy bodies in vivo and accelerates α-synuclein aggregation in vitro.
    Welander H; Bontha SV; Näsström T; Karlsson M; Nikolajeff F; Danzer K; Kostka M; Kalimo H; Lannfelt L; Ingelsson M; Bergström J
    Biochem Biophys Res Commun; 2011 Aug; 412(1):32-8. PubMed ID: 21798243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-Synuclein Disease Mutations Are Structurally Defective and Locally Affect Membrane Binding.
    Robotta M; Cattani J; Martins JC; Subramaniam V; Drescher M
    J Am Chem Soc; 2017 Mar; 139(12):4254-4257. PubMed ID: 28298083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cu2+ binding modes of recombinant alpha-synuclein--insights from EPR spectroscopy.
    Drew SC; Leong SL; Pham CL; Tew DJ; Masters CL; Miles LA; Cappai R; Barnham KJ
    J Am Chem Soc; 2008 Jun; 130(24):7766-73. PubMed ID: 18494470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces.
    Clayton JC; Hughes E; Middleton DA
    Biochemistry; 2005 Dec; 44(51):17016-26. PubMed ID: 16363815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles.
    Zhu M; Qin ZJ; Hu D; Munishkina LA; Fink AL
    Biochemistry; 2006 Jul; 45(26):8135-42. PubMed ID: 16800638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity.
    Wang X; Moualla D; Wright JA; Brown DR
    J Neurochem; 2010 May; 113(3):704-14. PubMed ID: 20141569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.